Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ocugen
Biotech
Ray shines a light on $125M round targeting genetic eye therapy
Ray Therapeutics has announced the closing of a $125 million series B financing to support candidates for patients with retinal degeneration.
Will Maddox
Apr 21, 2026 10:33am
Ocugen’s CEO wants to bring gene therapy to the masses
Apr 16, 2026 9:00am
Ocugen eye disease gene therapy nabs ph. 2 win
Mar 24, 2026 10:40am
Ocugen update charts course for rivalry with Apellis, Astellas
Jan 15, 2026 9:22am
Carisma's lifeline disappears as reverse merger plans break down
Sep 18, 2025 10:40am
Novartis R&D chief Jay Bradner departs—Chutes & Ladders
Sep 2, 2022 9:30am
